Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan
Authors
Keywords
ChAd63-KH vaccine, clinical trial, safety, immunogenicity, PKDL, leishmaniasis, Sudan, transcriptomics
Journal
MOLECULAR THERAPY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-03-27
DOI
10.1016/j.ymthe.2021.03.020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HIV therapeutic vaccines aimed at intensifying combination antiretroviral therapy
- (2020) Sonia Moretti et al. Expert Review of Vaccines
- The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease
- (2020) Anna Rosa Garbuglia et al. Frontiers in Immunology
- Active surveillance identified a neglected burden of macular cases of Post Kala-azar Dermal Leishmaniasis in West Bengal
- (2019) Ritika Sengupta et al. PLoS Neglected Tropical Diseases
- Susceptibility to leishmaniasis is affected by host SLC11A1 gene polymorphisms: a systematic review and meta-analysis
- (2019) Georgia G. Braliou et al. PARASITOLOGY RESEARCH
- Biomarkers in Post-kala-azar Dermal Leishmaniasis
- (2019) Eduard E. Zijlstra Frontiers in Cellular and Infection Microbiology
- Post-Kala-Azar Dermal Leishmaniasis as a Reservoir for Visceral Leishmaniasis Transmission
- (2019) Epke A. Le Rutte et al. TRENDS IN PARASITOLOGY
- Cysteine Cathepsins in Tumor-Associated Immune Cells
- (2019) Tanja Jakoš et al. Frontiers in Immunology
- Vaccine candidates against leishmania under current research
- (2018) Salvador Iborra et al. Expert Review of Vaccines
- Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives
- (2018) Fabiana Alves et al. CLINICAL MICROBIOLOGY REVIEWS
- Quantifying the infectiousness of post-kala-azar dermal leishmaniasis towards sandflies
- (2018) Dinesh Mondal et al. CLINICAL INFECTIOUS DISEASES
- Drug Discovery for Kinetoplastid Diseases: Future Directions
- (2018) Srinivasa P. S. Rao et al. ACS Infectious Diseases
- A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH
- (2017) Mohamed Osman et al. PLoS Neglected Tropical Diseases
- Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme.
- (2017) Eduard E. Zijlstra et al. PLoS Neglected Tropical Diseases
- Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys
- (2016) Erica N. Borducchi et al. NATURE
- Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
- (2016) Maxim V. Kuleshov et al. NUCLEIC ACIDS RESEARCH
- The immunology of post-kala-azar dermal leishmaniasis (PKDL)
- (2016) Eduard E. Zijlstra Parasites & Vectors
- Status of vaccine research and development of vaccines for leishmaniasis
- (2016) Portia M. Gillespie et al. VACCINE
- Leishmania vaccine development: exploiting the host–vector–parasite interface
- (2015) SG Reed et al. Expert Review of Vaccines
- Modular Multiantigen T Cell Epitope-Enriched DNA Vaccine Against Human Leishmaniasis
- (2014) S. Das et al. Science Translational Medicine
- Post kala-azar dermal leishmaniasis: an unresolved mystery
- (2014) Debanjan Mukhopadhyay et al. TRENDS IN PARASITOLOGY
- Causal analysis approaches in Ingenuity Pathway Analysis
- (2013) Andreas Krämer et al. BIOINFORMATICS
- Immunogenicity of 2 Doses of HPV Vaccine in Younger Adolescents vs 3 Doses in Young Women
- (2013) Simon R. M. Dobson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Case study for a vaccine against leishmaniasis
- (2013) Jorge Alvar et al. VACCINE
- Polymorphism in the HASPB Repeat Region of East African Leishmania donovani Strains
- (2013) Arie Zackay et al. PLoS Neglected Tropical Diseases
- Trafficking and release of Leishmania metacyclic HASPB on macrophage invasion
- (2012) Lorna M. MacLean et al. CELLULAR MICROBIOLOGY
- Therapeutic Vaccination With Recombinant Adenovirus Reduces Splenic Parasite Burden in Experimental Visceral Leishmaniasis
- (2012) A. Maroof et al. JOURNAL OF INFECTIOUS DISEASES
- Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector
- (2012) Geraldine A. O’Hara et al. JOURNAL OF INFECTIOUS DISEASES
- Leishmaniasis Worldwide and Global Estimates of Its Incidence
- (2012) Jorge Alvar et al. PLoS One
- CD8+ T Cells in Leishmania Infections: Friends or Foes?
- (2012) Simona Stäger et al. Frontiers in Immunology
- Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis—A meta-analysis
- (2009) Sassan Noazin et al. VACCINE
- B7-H1 Blockade Increases Survival of Dysfunctional CD8+ T Cells and Confers Protection against Leishmania donovani Infections
- (2009) Trupti Joshi et al. PLoS Pathogens
- First generation leishmaniasis vaccines: A review of field efficacy trials
- (2008) Sassan Noazin et al. VACCINE
- Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment
- (2007) Ahmed Mudawi Musa et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started